102 related articles for article (PubMed ID: 16757342)
1. Regulation of the expression of tropomyosins and actin cytoskeleton by ras transformation.
Prasad GL
Methods Enzymol; 2006; 407():410-22. PubMed ID: 16757342
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Par-4 by oncogenic Ras.
Vasudevan KM; Ranganathan P; Rangnekar VM
Methods Enzymol; 2006; 407():422-42. PubMed ID: 16757343
[TBL] [Abstract][Full Text] [Related]
4. Sorting of tropomyosin isoforms in synchronised NIH 3T3 fibroblasts: evidence for distinct microfilament populations.
Percival JM; Thomas G; Cock TA; Gardiner EM; Jeffrey PL; Lin JJ; Weinberger RP; Gunning P
Cell Motil Cytoskeleton; 2000 Nov; 47(3):189-208. PubMed ID: 11056521
[TBL] [Abstract][Full Text] [Related]
5. Tropomyosin-based regulation of the actin cytoskeleton in time and space.
Gunning P; O'Neill G; Hardeman E
Physiol Rev; 2008 Jan; 88(1):1-35. PubMed ID: 18195081
[TBL] [Abstract][Full Text] [Related]
6. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
7. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
8. Amino terminal, but not the carboxy terminal, sequences of tropomyosin-1 are essential for the induction of stress fiber assembly in neoplastic cells.
Bharadwaj S; Shah V; Tariq F; Damartoski B; Prasad GL
Cancer Lett; 2005 Nov; 229(2):253-60. PubMed ID: 16122869
[TBL] [Abstract][Full Text] [Related]
9. Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.
Sukezane T; Oneyama C; Kakumoto K; Shibutani K; Hanafusa H; Akagi T
Oncogene; 2005 Aug; 24(36):5648-55. PubMed ID: 16007212
[TBL] [Abstract][Full Text] [Related]
10. Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene.
Bhattacharya B; Ciardiello F; Salomon DS; Cooper HL
Oncogene Res; 1988; 3(1):51-65. PubMed ID: 3060798
[TBL] [Abstract][Full Text] [Related]
11. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells.
Masuda A; Takenaga K; Kondoh F; Fukami H; Utsumi K; Okayama H
Oncogene; 1996 May; 12(10):2081-8. PubMed ID: 8668333
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
13. Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts.
McMichael BK; Kotadiya P; Singh T; Holliday LS; Lee BS
Bone; 2006 Oct; 39(4):694-705. PubMed ID: 16765662
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogene.
Lombardi L; Ballinari D; Bongarzone I; Migliari M; Mondellini P; Traversari C; Modina S
Cell Motil Cytoskeleton; 1990; 15(4):220-9. PubMed ID: 1692516
[TBL] [Abstract][Full Text] [Related]
15. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
Martín-Encabo S; Santos E; Guerrero C
Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
[TBL] [Abstract][Full Text] [Related]
16. Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton.
O'Neill GM; Stehn J; Gunning PW
Semin Cancer Biol; 2008 Feb; 18(1):35-44. PubMed ID: 17942320
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
[TBL] [Abstract][Full Text] [Related]
18. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.
Shah V; Braverman R; Prasad GL
Somat Cell Mol Genet; 1998 Sep; 24(5):273-80. PubMed ID: 10696235
[TBL] [Abstract][Full Text] [Related]
19. Influence of Ki-ras-driven oncogenic transformation on the protein network of murine fibroblasts.
Recktenwald CV; Mendler S; Lichtenfels R; Kellner R; Seliger B
Proteomics; 2007 Feb; 7(3):385-98. PubMed ID: 17211828
[TBL] [Abstract][Full Text] [Related]
20. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
Prasad GL; Masuelli L; Raj MH; Harindranath N
Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
